Influenza vaccination of cancer patients during PD-1 blockade induces serological protection but may raise the risk for immune-related adverse events.
about
Influenza vaccination of cancer patients during PD-1 blockade induces serological protection but may raise the risk for immune-related adverse events.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Influenza vaccination of cance ...... immune-related adverse events.
@en
Influenza vaccination of cance ...... immune-related adverse events.
@nl
type
label
Influenza vaccination of cance ...... immune-related adverse events.
@en
Influenza vaccination of cance ...... immune-related adverse events.
@nl
prefLabel
Influenza vaccination of cance ...... immune-related adverse events.
@en
Influenza vaccination of cance ...... immune-related adverse events.
@nl
P2093
P2860
P1476
Influenza vaccination of cance ...... immune-related adverse events.
@en
P2093
Adrian Egli
Alfred Zippelius
Astrid Hertig
Beat Müller
Catharina Balmelli
Dominik Vogt
Lukas Kaufmann
Michal Stanczak
Mohammedyaseen Syedbasha
Oliver Gautschi
P2860
P2888
P356
10.1186/S40425-018-0353-7
P577
2018-05-22T00:00:00Z
P6179
1104089373